Source: Investing.com ↗

BMO reiterates Eli Lilly stock rating on incretin growth outlook

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,246.17

+0.88%

ETH/USDT

$2,748.34

+0.60%

ZEC/USDT

$1,624.65

+7.62%

XRP/USDT

$1.62

+6.30%